How many drugs treat Postoperative Ocular Pain?

Drug Landscape tracks 10 marketed treatments for Postoperative Ocular Pain (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/postoperative-ocular-pain.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Postoperative Ocular Pain — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postoperative Ocular Pain (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Postoperative Ocular Pain, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Durezol	DIFLUPREDNATE	Novartis	difluprednate	Glucocorticoid receptor	2008-01-01
Nevanac	NEPAFENAC	Harrow Health	Nonsteroidal Anti-inflammatory Drug [EPC]	Prostaglandin G/H synthase 2	2005-01-01
Xibrom	BROMFENAC	Bausch Health	Nonsteroidal Anti-inflammatory Drug	Prostaglandin G/H synthase 2	2005-01-01
Voltaren	DICLOFENAC	Hisamitsu Pharmaceutical Co., Inc	Nonsteroidal Anti-inflammatory Drug	Prostaglandin G/H synthase 2	1988-01-01
Arthrotec	Diclofenac Sodium	Pfizer	diclofenac	Acid-sensing ion channel 3	1988-01-01
Tham	trometamol	Pfizer	trometamol		1965-01-01
Nevanac	Nevanac	Santa Casa de Misericordia de Santos		Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase
NEPA	NEPA	Harrow Eye		Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase
Xibrom	Xibrom	Bp Consulting, Inc		Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase
Yellox	Yellox	University of Trieste		Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 2 drugs in Postoperative Ocular Pain
Bausch Health · 1 drug in Postoperative Ocular Pain
Bp Consulting, Inc · 1 drug in Postoperative Ocular Pain
Harrow Eye · 1 drug in Postoperative Ocular Pain
Harrow Health · 1 drug in Postoperative Ocular Pain
Hisamitsu Pharmaceutical Co., Inc · 1 drug in Postoperative Ocular Pain
Novartis · 1 drug in Postoperative Ocular Pain
Santa Casa de Misericordia de Santos · 1 drug in Postoperative Ocular Pain
· 1 drug in Postoperative Ocular Pain
University of Trieste · 1 drug in Postoperative Ocular Pain

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Postoperative Ocular Pain:

Cite this brief

Drug Landscape (2026). Postoperative Ocular Pain — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/postoperative-ocular-pain. Accessed 2026-06-10.

Postoperative Ocular Pain full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing